| -- Neupro® (Rotigotine Transdermal System) is approved to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary restless legs syndrome -- Neupro® is a dopamine agonist patch that provides continuous drug delivery for patients with PD and RLS -- Over 100,000 patients have been treated with Neupro® worldwide and seven pivotal trials demonstrate efficacy, safety and tolerability for PD and RLS -- Neupro® will be available in...continued UCBJY |
Tuesday, April 3, 2012
Neupro( Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment